查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1983872

神經系統醫療設備市場：依產品、應用、最終用戶和通路分類－2026-2032年全球市場預測

Neurology Devices Market by Product, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，神經醫療設備市場價值將達到 139.6 億美元，到 2026 年將成長至 153.3 億美元，到 2032 年將達到 282.1 億美元，複合年成長率為 10.57%。

主要市場統計數據
基準年 2025 139.6億美元
預計年份：2026年 153.3億美元
預測年份 2032 282.1億美元
複合年成長率 (%) 10.57%

在技​​術快速發展和監管變革的時代，本文探討了塑造先進神經醫療設備。

神經醫療設備領域正處於一個關鍵的轉折點，技術的飛躍和臨床實踐的變革正在迅速改變患者照護通訊協定。隨著精準醫療的興起，器材研發人員正在整合先進的感測器、人工智慧和尖端材料，以提供根據每位患者獨特的神經生理特徵量身定做的個人化治療方案。這種向個人化治療的轉變源於不斷累積的臨床證據，這些證據表明個人化治療能夠改善治療效果並減少不利事件。

新興技術、臨床範式轉變和跨學科整合如何重新定義神經醫療設備的發展和患者照護路徑。

在跨學科整合和以病人為中心的設計理念的驅動下，一場變革浪潮正在重塑神經醫療設備領域。神經影像學和術中導航技術的快速發展，使得微創手術成為新的治療標準，顯著縮短了手術時間，並加快了患者康復。同時，植入式神經調控系統的普及，正透過封閉回路型回饋機制，顯著提高療效和安全性，從而重新定義從慢性疼痛到神經退化性疾病等多種疾病的治療模式。

評估 2025 年美國關稅對神經醫療設備。

美國在2025年實施的關稅政策為神經醫療設備生態系統帶來了巨大挑戰，影響價值鏈的每一個環節。面對進口零件關稅的上漲，製造商被迫重新思考籌資策略，一些公司將部分生產轉移到更靠近終端市場的地方，以降低成本。雖然這種近岸生產模式在一定程度上緩解了供應鏈的脆弱性，但也需要對國內基礎設施進行大量資本投資。

闡明神經醫療設備領域中，產品、應用、最終用戶和通路的關鍵細分模式，進而推動策略決策。

關鍵細分市場分析揭示了影響技術採納和投資的微妙因素，突顯了臨床和商業性優先事項的交會點。產品趨勢評估表明，從腦脊髓液（CSF）管理裝置（如腦外引流和腦分流器）到介入性神經病學工具（如動脈瘤栓塞術、球囊血管成形術和支架、神經血栓切除術以及神經血管導管），每項技術都有其獨特的創新需求。在動脈瘤栓塞術領域，栓塞線圈、血流導引裝置和液體栓塞劑因其在降低復發率方面的作用而備受關注；而腦球囊血管成形術和支架策略則著重於最佳化球囊閉塞、頸動脈支架和濾器裝置的器械特性。同樣，神經血栓切除術的進展凸顯了血栓移除裝置、勒除器器和抽吸系統的發展；而不斷擴展的神經刺激療法領域則包括深部腦部刺激、胃電刺激、薦椎神經刺激、脊髓刺激和迷走神經刺激。最後，動脈瘤夾、神經科學用內視鏡、立體定位手術系統和超音波吸引器等神經外科器械的進步，也反映了人們對精準性和微創性的持續追求。

分析美洲、歐洲、中東和非洲以及亞太地區神經醫療設備普及路徑所面臨的區域機會和挑戰。

區域趨勢在塑造神經醫療設備市場的發展軌跡中發揮著至關重要的作用，因為不同的醫療基礎設施、報銷系統和患者群體都會影響產品的普及率。在美洲，成熟的大學醫院網路和有利於數位療法的法規環境正在推動先進監測和神經調控系統的快速普及。然而，控制醫療成本的壓力以及向價值醫療模式的轉變，使得人們更加關注產品的長期臨床效益。

透過對主要企業和創新者的分析，突顯神經醫療設備。

主要企業和新興創新者正透過策略聯盟、定向研發投資和開發整合式醫療模式，樹立新的產業標竿。成熟企業正深化與學術機構的夥伴關係，共同開發融合先進感測技術與自適應演算法的下一代神經刺激平台。同時，創業投資支持的Start-Ups在生物電子和軟體機器人領域開拓創新，成功展示了概念驗證（PoC）項目，並吸引了許多授權和收購者的注意。

為產業領導者提供策略藍圖，幫助他們應對監管的複雜性，利用技術進步，並鞏固其在神經醫療設備領域的地位。

產業領導者必須採取前瞻性策略，使研發重點與不斷發展的臨床和監管範式保持一致。企業應優先開發能夠支援多種適應症的平台技術，從而最大限度地提高投資回報率並促進跨職能協同效應。投資強大的數據分析和遠端監測能力將有助於產生真實世界數據 (RWE)，而真實世界數據對於獲得有利的報銷條款和支付方協議正變得越來越重要。

採用綜合研究途徑，結合一手訪談、二手資料分析和統計檢驗，以確保對神經醫療設備有可靠的了解。

本研究採用多階段方法，確保研究結果的可靠性和有效性。主要資料收集包括對關鍵意見領袖（KOL）進行結構化訪談，訪談對象包括神經科、介入放射科醫生和醫療設備工程師，旨在獲取他們對未滿足需求和創新瓶頸的第一手觀點。次要研究資料來源包括監管資料庫、臨床試驗註冊資訊和同行評審文獻，以提供有關產品平臺和核准趨勢的背景資訊。

本報告整合了關鍵發現和策略挑戰，揭示了神經醫療設備市場的未來發展方向和投資機會。

神經系統醫療器材領域的特點是技術快速發展、醫保報銷模式不斷演變、監管環境日益複雜。分析表明，整合數位智慧、深化策略夥伴關係並保持敏捷生產體系的企業更有可能取得成功。透過封閉回路型調控和微創手術實現的個人化治療將推動下一波臨床突破。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：神經醫療設備市場：依產品分類

  • 腦脊髓液管理裝置
    • 神經系統外引流
    • 腦分流
  • 介入性神經病學
    • 動脈瘤彈簧圈栓塞術及栓塞術
      • 栓塞線圈
      • 血液旁路裝置
      • 液態栓塞劑
    • 腦血管球囊成形術及支架植入術
      • 球囊阻塞裝置
      • 頸動脈支架
      • 過濾裝置
    • 神經血栓切除術
      • 血栓清除器
      • 勒除器裝置
      • 吸力裝置
    • 神經血管導管
  • 神經刺激
    • 深部腦部刺激
    • 胃電刺激
    • 薦椎神經刺激
    • 脊髓刺激療法
    • 迷走神經刺激
  • 神經外科器械
    • 動脈瘤夾
    • 神經科學用內視鏡
    • 定位系統
    • 超音波吸引器

第9章：神經醫療設備市場：依應用領域分類

  • 慢性疼痛
  • 癲癇和癲癇發作
    • 癲癇的診斷和監測
    • 癲癇控制裝置
  • 精神疾病
    • 焦慮
    • 憂鬱症
    • 思覺失調症
  • 多發性硬化症（MS）
  • 神經退化性疾病
    • 阿茲海默症
    • 肌萎縮側索硬化症（ALS）
    • 亨丁頓舞蹈症
    • 帕金森氏症
  • 神經血管疾病
  • 脊髓損傷
  • 中風
    • 用於治療出血性中風的醫療設備
    • 用於治療缺血性中風的醫療設備
    • 中風復健設備
  • 創傷性腦損傷（TBI）

第10章：神經醫療設備市場：依最終用戶分類

  • 學術和研究機構
  • 診斷中心
  • 居家照護
  • 醫院
  • 神經科診所
  • 復健中心

第11章：神經醫療設備市場：依分銷管道分類

  • 離線
  • 線上

第12章 神經系統醫療設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：神經醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 神經醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國神經醫療設備市場

第16章：中國神經醫療設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Acandis GmbH
  • B. Braun SE
  • Boston Scientific Corporation
  • Esaote SpA
  • GE HealthCare Technologies, Inc.
  • Integra LifeSciences Holdings
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Natus Medical Inc.
  • Nihon Kohden Corporation
  • Penumbra Inc.
  • Rapid Medical Ltd.
  • Siemens Healthcare GmbH
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-F6513A06BEEC

The Neurology Devices Market was valued at USD 13.96 billion in 2025 and is projected to grow to USD 15.33 billion in 2026, with a CAGR of 10.57%, reaching USD 28.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 13.96 billion
Estimated Year [2026] USD 15.33 billion
Forecast Year [2032] USD 28.21 billion
CAGR (%) 10.57%

Discover the Unfolding Innovations and Challenges Shaping Advanced Neurology Devices in an Era of Rapid Technological Evolution and Regulatory Shifts

The field of neurology devices stands at a pivotal juncture, where breakthroughs in technology and shifts in clinical practice are rapidly altering patient care protocols. As precision medicine gains momentum, device developers are integrating sophisticated sensors, artificial intelligence, and advanced materials to deliver tailored therapies that align with the unique neurophysiological profiles of patients. This drive toward personalization is fueled by a growing body of clinical evidence demonstrating improved outcomes and reduced adverse events.

Regulatory landscapes are also evolving, with agencies worldwide emphasizing post-market surveillance, cybersecurity standards, and streamlined pathways for digital therapeutics. At the same time, healthcare providers are under mounting pressure to demonstrate value, leading to increased collaboration between device manufacturers, payers, and clinical networks. Against this backdrop, a clear understanding of the interplay between innovation, regulation, and market access has never been more critical for stakeholders seeking to navigate complexity and capitalize on emerging opportunities.

How Emerging Technologies, Clinical Paradigm Shifts, and Cross-Disciplinary Integration Are Redefining Neurology Device Development and Patient Care Pathways

A wave of transformative shifts is reshaping the neurology devices landscape, driven by cross-disciplinary convergence and patient-centric design philosophies. Rapid advances in neuroimaging and intraoperative navigation have enabled minimally invasive interventions to become the new standard of care, reducing procedure times and accelerating recovery. In parallel, the proliferation of implantable neuromodulation systems is redefining therapeutic paradigms for conditions ranging from chronic pain to neurodegenerative disorders, with closed-loop feedback mechanisms enhancing efficacy and safety.

Meanwhile, the integration of machine learning algorithms into diagnostic platforms is unlocking predictive capabilities that were previously unattainable. This is complemented by the emergence of digital biomarkers, which harness wearable sensors and remote monitoring to capture rich datasets in real time. As industry players forge partnerships with technology innovators and academic centers, new business models are taking shape that prioritize outcome-based agreements and digital services alongside traditional capital equipment. Consequently, stakeholders must remain agile, anticipating how these converging trends will dictate the next frontier of clinical performance and commercial success.

Assessing the Aggregate Consequences of 2025 United States Tariffs on Neurology Device Supply Chains, Cost Structures, and Competitive Dynamics

The implementation of United States tariffs in 2025 has introduced significant headwinds for the neurology devices ecosystem, affecting every stage of the value chain. Manufacturers facing elevated duties on imported components have had to reassess sourcing strategies, with some relocating portions of production closer to end markets to mitigate cost impacts. This shift toward nearshoring has alleviated certain supply chain vulnerabilities, yet it has also necessitated substantial capital investment in domestic infrastructure.

On the demand side, hospitals and clinics are increasingly scrutinizing total cost of ownership, compelling device suppliers to justify price adjustments with demonstrable clinical and operational benefits. In response, vendors are accelerating innovation cycles, embedding connectivity features that support remote diagnostics and predictive maintenance to counterbalance tariff-induced price pressures. At the same time, collaborative consortia are emerging to share best practices in procurement and logistics, reinforcing resilience against future trade policy fluctuations. As a result, companies that proactively adapt their manufacturing footprint and value propositions are better positioned to sustain growth in this new trade environment.

Unveiling Key Segmentation Patterns Across Products, Applications, End Users, and Distribution Channels That Drive Strategic Decision Making in Neurology Devices

Critical segmentation analysis reveals nuanced drivers of adoption and investment, highlighting where clinical and commercial priorities intersect. When evaluating the product landscape, it becomes evident that technologies spanning CSF Management Devices-such as cerebral external drainage and cerebral shunts-and Interventional Neurology tools for aneurysm coiling and embolization, balloon angioplasty & stents, neurothromboectomy, and neurovascular catheters each present distinct innovation imperatives. Within aneurysm coiling and embolization, embolic coils, flow diversion devices, and liquid embolic reagents command attention for their role in reducing recurrence rates, while cerebral balloon angioplasty & stents strategies focus on optimizing device profiles for balloon occlusion, carotid artery stents, and filter devices. Equally, the evolution of neurothromboectomy highlights clot retrievers, snare devices, and suction aspiration systems, and the expanding realm of neurostimulation encompasses deep brain stimulation, gastric electric stimulation, sacral nerve stimulation, spinal cord stimulation, and vagus nerve stimulation. Finally, advances in neurosurgery devices like aneurysm clips, neuroendoscopes, stereotactic systems, and ultrasonic aspirators underscore the ongoing push toward precision and minimal invasiveness.

Similarly, application-based segmentation underscores the varying unmet needs across therapeutic areas. In chronic pain management, the emphasis is on long-term safety and patient comfort, whereas epilepsy & seizure disorders demand robust solutions for diagnosis & monitoring of epilepsy and seizure control devices. Treatment pathways for mental health disorders-including anxiety, depression, and schizophrenia-are evolving with neurostimulation and closed-loop monitoring, and multiple sclerosis strategies must accommodate both relapsing and progressive forms. Neurodegenerative disorder profiles span Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and Parkinson's disease, each requiring distinct device capabilities. Neurovascular disorders present acute intervention challenges, spinal cord injuries call for regenerative and assistive technologies, and stroke care differentiates between hemorrhagic stroke devices, ischemic stroke devices, and stroke rehabilitation devices. Traumatic brain injury remains a high-priority area for intracranial pressure management and neurorehabilitation.

On the end-user front, the ecosystem stretches from academic & research institutes and diagnostic centers to home care, hospitals, neurology clinics, and rehabilitation centers, each setting imposing unique training, reimbursement, and integration requirements. Distribution channels, whether offline or online, further shape go-to-market strategies, impacting everything from product demonstrations to post-sales support.

Analyzing Regional Opportunities and Challenges in the Americas, Europe Middle East Africa, and Asia Pacific That Shape Neurology Device Adoption Pathways

Regional dynamics play an outsized role in shaping the trajectory of neurology device markets, as diverse healthcare infrastructures, reimbursement frameworks, and patient demographics influence adoption rates. In the Americas, a well-established network of academic medical centers and a favorable regulatory climate for digital therapeutics support rapid uptake of advanced monitoring and neuromodulation systems. Yet cost containment pressures and shifts toward value-based care models are driving heightened scrutiny of long-term clinical benefits.

Europe Middle East Africa embodies a mosaic of markets where regulatory harmonization under evolving directives intersects with national payer negotiations. This environment creates both barriers and opportunities for device innovators, particularly those leveraging real-world evidence to substantiate outcomes. Growing investments in neurovascular centers of excellence are enhancing the profile of interventional neurology and stroke rehabilitation technologies.

In Asia Pacific, dynamic growth is underpinned by expanding healthcare budgets, rising incidence of neurological disorders, and government initiatives to bolster domestic manufacturing capabilities. Local partnerships and licensing agreements have become essential pathways for global manufacturers seeking to navigate diverse regulatory landscapes and accelerate market entry. Consequently, stakeholders must adopt differentiated regional strategies that account for local standards, reimbursement pathways, and clinician training requirements.

Profiling Leading Players and Innovators to Highlight Strategic Collaborations, Innovation Pathways, and Competitive Differentiators in Neurology Devices

Leading players and rising innovators are establishing new benchmarks through strategic collaborations, targeted research and development investments, and the creation of integrated care models. Established firms are deepening partnerships with academic centers to co-develop next-generation neurostimulation platforms that incorporate advanced sensing and adaptive algorithms. Concurrently, venture-backed startups are pioneering bioelectronics and soft robotics, demonstrating proof-of-concept successes that are attracting licensing and acquisition interest.

Partnerships between device manufacturers and digital health providers are expanding the scope of remote patient management, with cross-industry alliances enabling the incorporation of cloud-based analytics and telemedicine workflows. Patent portfolios and regulatory approvals serve as key differentiators, and companies that maintain a balanced mix of incremental enhancements and disruptive breakthroughs are consistently outperforming peers in clinical acceptance. As M&A activity accelerates in areas such as minimally invasive interventional neurology and closed-loop neuromodulation, market leadership hinges on the ability to integrate complementary assets and scale solutions across global markets.

Strategic Roadmap for Industry Leaders to Navigate Regulatory Complexities, Capitalize on Technological Advances, and Strengthen Position in Neurology Devices

Industry leaders must adopt a forward-looking strategy that aligns R&D priorities with evolving clinical and regulatory paradigms. Companies should prioritize the development of platform technologies capable of supporting multiple indications, thereby maximizing return on investment and facilitating cross-functional synergies. Investing in robust data analytics and remote monitoring capabilities will enhance real-world evidence generation, which is increasingly vital for securing favorable reimbursement and payer contracts.

At the same time, regional supply chain diversification and nearshoring initiatives should be advanced to buffer against future trade policy disruptions. Engaging early with regulatory agencies on digital health guidelines and post-market surveillance expectations can streamline approval pathways and minimize time to market. Finally, forging collaborative ecosystems with healthcare providers, technology firms, and patient advocacy groups will accelerate adoption and ensure that product roadmaps remain closely aligned with unmet clinical needs.

Comprehensive Research Approach Combining Primary Interviews, Secondary Data Analysis, and Statistical Validation to Ensure Robust Insights in Neurology Devices

This research employs a multi-phased approach to ensure the integrity and relevance of insights. Primary data collection involved structured interviews with key opinion leaders, including neurologists, interventional radiologists, and device engineers, to capture firsthand perspectives on unmet needs and innovation bottlenecks. Secondary research sources encompassed regulatory databases, clinical trial registries, and peer-reviewed literature to contextualize product pipelines and approval trends.

Quantitative analysis was conducted using a rigorous data triangulation framework that reconciled manufacturer disclosures, hospital procurement records, and publicly available financial reports. Statistical validation techniques were applied to identify significant trends and correlations. An expert advisory board reviewed intermediate findings to refine assumptions and interpret emerging themes, thereby ensuring that the final deliverables reflect both empirical evidence and real-world clinical practice.

Synthesizing Key Findings and Strategic Imperatives to Illuminate Future Directions and Investment Opportunities in the Neurology Devices Landscape

The neurology devices landscape is defined by rapid technological advancement, shifting reimbursement models, and increasingly complex regulatory frameworks. Through this analysis, it is clear that success will favor organizations that integrate digital intelligence, deepen strategic partnerships, and maintain agile manufacturing footprints. Personalization of therapies through closed-loop neuromodulation and minimally invasive interventions is set to drive the next wave of clinical breakthroughs.

Looking forward, industry players that invest in scalable platform technologies and robust evidence generation will be best positioned to capture new opportunities. Cross-border collaboration and adaptive regulatory engagement will accelerate commercialization, ultimately improving patient outcomes and unlocking sustainable growth. The insights presented here form a blueprint for navigating uncertainty and charting a course toward continued innovation in neurology care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurology Devices Market, by Product

  • 8.1. CSF Management Devices
    • 8.1.1. Cerebral External Drainage
    • 8.1.2. Cerebral Shunts
  • 8.2. Interventional Neurology
    • 8.2.1. Aneurysm Coiling and Embolization
      • 8.2.1.1. Embolic Coils
      • 8.2.1.2. Flow Diversion Devices
      • 8.2.1.3. Liquid Embolic Reagents
    • 8.2.2. Cerebral Balloon Angioplasty & Stents
      • 8.2.2.1. Balloon Occlusion Devices
      • 8.2.2.2. Carotid Artery Stents
      • 8.2.2.3. Filter Devices
    • 8.2.3. Neurothromobectomy
      • 8.2.3.1. Clot Retrievers
      • 8.2.3.2. Snare Devices
      • 8.2.3.3. Suction Aspiration Devices
    • 8.2.4. Neurovascular Catheters
  • 8.3. Neurostimulation
    • 8.3.1. Deep Brain Stimulation
    • 8.3.2. Gastric Electric Stimulation
    • 8.3.3. Sacral Nerve Stimulation
    • 8.3.4. Spinal Cord Stimulation
    • 8.3.5. Vagus Nerve Stimulation
  • 8.4. Neurosurgery Devices
    • 8.4.1. Aneurysm Clips
    • 8.4.2. Neuroendoscopes
    • 8.4.3. Stereotactic Systems
    • 8.4.4. Ultrasonic Aspirators

9. Neurology Devices Market, by Application

  • 9.1. Chronic Pain
  • 9.2. Epilepsy & Seizure Disorders
    • 9.2.1. Diagnosis & Monitoring of Epilepsy
    • 9.2.2. Seizure Control Devices
  • 9.3. Mental Health Disorders
    • 9.3.1. Anxiety
    • 9.3.2. Depression
    • 9.3.3. Schizophrenia
  • 9.4. Multiple Sclerosis (MS)
  • 9.5. Neurodegenerative Disorders
    • 9.5.1. Alzheimer's Disease
    • 9.5.2. Amyotrophic Lateral Sclerosis (ALS)
    • 9.5.3. Huntington's Disease
    • 9.5.4. Parkinson's Disease
  • 9.6. Neurovascular Disorders
  • 9.7. Spinal Cord Injuries
  • 9.8. Stroke
    • 9.8.1. Hemorrhagic Stroke Devices
    • 9.8.2. Ischemic Stroke Devices
    • 9.8.3. Stroke Rehabilitation Devices
  • 9.9. Traumatic Brain Injury (TBI)

10. Neurology Devices Market, by End User

  • 10.1. Academic & Research Institutes
  • 10.2. Diagnostic Centers
  • 10.3. Home Care
  • 10.4. Hospitals
  • 10.5. Neurology Clinics
  • 10.6. Rehabilitation Centers

11. Neurology Devices Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Neurology Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Neurology Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Neurology Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Neurology Devices Market

16. China Neurology Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Acandis GmbH
  • 17.7. B. Braun SE
  • 17.8. Boston Scientific Corporation
  • 17.9. Esaote SpA
  • 17.10. GE HealthCare Technologies, Inc.
  • 17.11. Integra LifeSciences Holdings
  • 17.12. Koninklijke Philips N.V.
  • 17.13. Masimo Corporation
  • 17.14. Medtronic PLC
  • 17.15. MicroPort Scientific Corporation
  • 17.16. Natus Medical Inc.
  • 17.17. Nihon Kohden Corporation
  • 17.18. Penumbra Inc.
  • 17.19. Rapid Medical Ltd.
  • 17.20. Siemens Healthcare GmbH
  • 17.21. Stryker Corporation
  • 17.22. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL EXTERNAL DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL EXTERNAL DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL EXTERNAL DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL SHUNTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL SHUNTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL SHUNTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY LIQUID EMBOLIC REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY LIQUID EMBOLIC REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY LIQUID EMBOLIC REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY BALLOON OCCLUSION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY BALLOON OCCLUSION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY BALLOON OCCLUSION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FILTER DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FILTER DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FILTER DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CLOT RETRIEVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CLOT RETRIEVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CLOT RETRIEVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SNARE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SNARE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SNARE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SUCTION ASPIRATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SUCTION ASPIRATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SUCTION ASPIRATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY GASTRIC ELECTRIC STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY GASTRIC ELECTRIC STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY GASTRIC ELECTRIC STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSIS & MONITORING OF EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSIS & MONITORING OF EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSIS & MONITORING OF EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SEIZURE CONTROL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SEIZURE CONTROL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SEIZURE CONTROL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANXIETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANXIETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANXIETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEPRESSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SCHIZOPHRENIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SCHIZOPHRENIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS (MS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS (MS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS (MS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ALZHEIMER'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ALZHEIMER'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS (ALS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS (ALS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS (ALS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HUNTINGTON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HUNTINGTON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HUNTINGTON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD INJURIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD INJURIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD INJURIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HEMORRHAGIC STROKE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HEMORRHAGIC STROKE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HEMORRHAGIC STROKE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE REHABILITATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE REHABILITATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE REHABILITATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY TRAUMATIC BRAIN INJURY (TBI), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY TRAUMATIC BRAIN INJURY (TBI), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY TRAUMATIC BRAIN INJURY (TBI), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 201. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 202. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 203. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 276. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 278. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 280. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 287. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 288. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 290. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 293. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 294. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 296. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 297. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 298. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 299. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC